Original paper
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Abstract
Cases of de novo immune thrombocytopenia (ITP), including a fatality, following SARS-CoV-2 vaccination in previously healthy recipients led to studying its impact in preexisting ITP. In this study, 4 data sources were analyzed: the Vaccine Adverse Events Reporting System (VAERS) for cases of de novo ITP; a 10-center retrospective study of adults with preexisting ITP receiving SARS-CoV-2 vaccination; and surveys distributed by the Platelet...
Paper Details
Title
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Published Date
Sep 29, 2021
Journal
Volume
139
Issue
10
Pages
1564 - 1574